HomeLatest NewsQuality NewsFDA approves new flu treatment

FDA approves new flu treatment

The Food and Drug Administration (FDA) has approved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza in patients 12 years of age and older who have been symptomatic for no more than 48 hours. “This is the first new antiviral flu treatment with a novel mechanism of action approved by the FDA in nearly 20 years. With thousands of people getting the flu every year, and many people becoming seriously ill, having safe and effective treatment alternatives is critical,” said FDA Commissioner Scott Gottlieb, MD.

Stay Connected

Unified Voice Newsletter

Events This Month

december

05dec12:00 pm1:00 pmBecoming the Employer of Choice - How Organizations Create "Stickiness" for their WorkersSDAHO Webinar

05dec12:00 pm1:00 pmRural Hospital Growth Is Possible: How Expanding Critical Services Can Drive ResultsAHA Webinar

06dec1:00 pm2:00 pmSubstance Misuse Prevention Strategies to Improve Public Health: A Focus on State PracticesODPHP Webinar

06dec1:30 pm2:30 pmMedical Complexities of Chronic Opioid UseHazelden Betty Ford Webinar

07dec11:30 am12:45 pmFacility Safety and Security in Health CareAHA Webinar


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact